Harpagophytum
Food supplement declared in France, declaration No 2022-8-16
Harpagophytum (VITAVEA - Laboratoires Vitarmonyl) is a food supplement declared in France. Status: retrait du marché annoncé pour le 27 July 2029. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- VITAVEA - Laboratoires Vitarmonyl
- Food business operator placing the product on the market
- Laboratoires VITARMONYL
- Status
- Retrait du marché annoncé pour le 27 July 2029
- Form
- Gélule
- Daily dose
- 1 gélule
- Directions for use
- Avaler avec un verre d'eau, le matin
- Not recommended for (according to the manufacturer)
- Calculs rénaux, Ulcère (estomac ou duodenum)
- Objectives stated by the manufacturer (these are not authorised claims)
- Articulations
Declaration 235559, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retrait du marché annoncé pour le 27 July 2029, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Harpagophytum procumbens | Racine | Extrait sec aqueux | 100 mg |
Additives
E504, E470b
Other ingredients
maltodextrine, Gélule végétale
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ne pas dépasser la dose recommandée. A consommer dans le cadre d'une alimentation variée et équilibrée et d'un mode de vie sain. A conserver dans un endroit sec et frais. Garder hors de portée des enfants. Ne pas utiliser en cas d'ulcère gastrique ou duodénal ou de calculs biliaires. Déconseillé en cas d'allergie à l'un des constituants.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.